[1]
Li, X., Zhai, Z., Zhu, Y. and Zhou, H. 2022. Comparison of Gefitinib in the treatment of patients with non-small cell lung cancer and clinical effects of Osimertinib and EGFR Gene mutation. Pakistan Journal of Medical Sciences. 38, 6 (Jul. 2022). DOI:https://doi.org/10.12669/pjms.38.6.5456.